DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 146 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,613,009 | -18.4% | 126,809 | -9.7% | 0.00% | 0.0% |
| Q2 2023 | $1,976,409 | +11.4% | 140,370 | +22.2% | 0.00% | 0.0% |
| Q1 2023 | $1,774,432 | -10.2% | 114,850 | -4.8% | 0.00% | 0.0% |
| Q4 2022 | $1,975,000 | -25.8% | 120,592 | -16.2% | 0.00% | 0.0% |
| Q3 2022 | $2,662,000 | +175.3% | 143,836 | +95.5% | 0.00% | – |
| Q2 2022 | $967,000 | +141.8% | 73,567 | +724.6% | 0.00% | – |
| Q1 2021 | $400,000 | -84.3% | 8,921 | -80.1% | 0.00% | -100.0% |
| Q4 2020 | $2,555,000 | +99.3% | 44,762 | +79.0% | 0.00% | 0.0% |
| Q3 2020 | $1,282,000 | -14.2% | 25,001 | -0.1% | 0.00% | 0.0% |
| Q2 2020 | $1,495,000 | +433.9% | 25,031 | +455.6% | 0.00% | – |
| Q4 2019 | $280,000 | -70.9% | 4,505 | -81.8% | 0.00% | – |
| Q3 2018 | $961,000 | -16.0% | 24,807 | -14.7% | 0.00% | -100.0% |
| Q2 2018 | $1,144,000 | – | 29,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |